Skip to main navigation Skip to search Skip to main content

Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer

  • Monica N. Schointuch
  • , Timothy P. Gilliam
  • , Jessica E. Stine
  • , Xiaoyun Han
  • , Chunxiao Zhou
  • , Paola A. Gehrig
  • , Kenneth Kim
  • , Victoria L. Bae-Jump
  • University of North Carolina at Chapel Hill
  • Jinan University

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalGynecologic Oncology
Volume134
Issue number2
DOIs
StatePublished - Aug 1 2014
Externally publishedYes

Disciplines

  • Endocrinology
  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this